Glenmark Pharmaceuticals gets FDA approval for Clindamycin Phosphate Foam
Glenmark Pharmaceuticals, an Indian pharma company, said that it has secured final approval for Clindamycin Phosphate Foam, 1% from the US Food and Drug Administration (FDA). Clindamycin Phosphate Foam is the generic version of Evoclin Foam, 1%, of Mylan Pharmaceuticals. Evoclin Foam is indicated for the treatment of acne. As per IQVIA, Evoclin Foam, 1% […]